Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Receivables (2021 - 2025)

Rxo's Receivables history spans 5 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Receivables rose 0.64% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, up 0.64%, while the annual FY2025 figure was $1.3 billion, 0.64% up from the prior year.
  • Receivables reached $1.3 billion in Q4 2025 per RXO's latest filing, up from $1.1 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.3 billion in Q4 2025 to a low of $716.0 million in Q1 2024.
  • Average Receivables over 5 years is $965.1 million, with a median of $1.0 billion recorded in 2022.
  • Peak YoY movement for Receivables: decreased 22.62% in 2023, then skyrocketed 64.99% in 2024.
  • A 5-year view of Receivables shows it stood at $1.0 billion in 2021, then fell by 11.76% to $900.0 million in 2022, then decreased by 16.22% to $754.0 million in 2023, then surged by 64.99% to $1.2 billion in 2024, then rose by 0.64% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Receivables are $1.3 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025).